Outlook: The Gut Microbiome
Outlook: The Gut Microbiome
Outlook: The Gut Microbiome
W
Editorial e are not alone in our bodies. Living inside every person are Contents
Herb Brody, Richard Hodson, trillions of microorganisms — bacteria, viruses, fungi and
Jenny Rooke S6 ECOSYSTEMS
other life forms that are collectively known as the microbi-
The hunt for a healthy
Art & Design ome. Various organs have distinct microbial inhabitants,
microbiome
Mohamed Ashour, Ffion Cleverley but the group that has attracted the most attention in bio- Understanding the ecosystem
medical research is the one in the gut.
Production
To better grasp the part that gut microbes play in health and disease, S9 Q&A
Nick Bruni, Karl Smart, Ian Pope,
Homing in on the molecules
Kay Lewis researchers from around the globe are investigating what makes a ‘good’
from microbes
gut microbiome (see page S6). There are, after all, hundreds of distinct Michael Fischbach studies
Sponsorship
bacterial species in the gut — some pathogenic and some beneficial. short-chain fatty acids
Stephen Brown, Nada Nabil,
Claudia Danci Computational biologist Eran Segal argues that collecting microbiome
S10 DRUGS
data would allow a ‘deep phenotyping’ approach that could transform
Marketing Gut reaction
drug discovery (S19). And the study of some health-promoting probi- The link with pharmaceuticals
Nicole Jackson
otic species is yielding biological insights that might promote drug
Project Manager development (S9). S12 AUTOIMMUNE DISEASE
Rebecca Jones When immunity goes wrong
Several diseases are now thought to be influenced by processes in the
The microbiome and disease
Creative Director
gut microbiome. Those include cancer (S16), autoimmune disorders
Wojtek Urbanek such as multiple sclerosis (S12) and autism spectrum disorder (S14). The S14 DEVELOPMENTAL DISORDERS
gut microbiome also strongly interacts with certain drugs, including Autism and the gut
Publisher Could there be a link?
some mental-health therapeutics, and influences their effects (S10).
Richard Hughes
With evidence mounting of the gut microbiome’s health significance, S16 CANCER
VP, Editorial synthetic biologists are looking to engineer the microbiome — both Fighting cancer with microbes
Stephen Pincock at the individual-species level and as an ecosystem — to thwart the Boosting response to therapies
Managing Editor
development of disease (S20). There is also growing public interest in S19 PERSPECTIVE
David Payne how the gut microbiome can be influenced — often focused on personal Another dimension for
dietary choices. Microbiologist Peter Turnbaugh reframes this as a drug discovery
Magazine Editor question not of which foods will benefit our health, but rather what Microbiota data could transform
Helen Pearson therapy, says Eran Segal
medical insights might be gleaned from the interactions between our
Editor-in-Chief gut microbes and what we eat (S23). S20 SYNTHETIC BIOLOGY
Magdalena Skipper Much more research is under way on the gut microbiome than can Engineering the microbiome
be covered in this Outlook, but this supplement gives a taste of the Modifying microbes for therapy
breadth of this robust field (S24). S23 PERSPECTIVE
We are pleased to acknowledge the financial support of Use diet as a tool,
Danone Nutricia Research in producing this Outlook. As always, Nature not a treatment
retains sole responsibility for all editorial content. Scientists can’t tell you what to
eat, says Peter J. Turnbaugh